Our Story
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us the experience and capabilities that also enable us to help people defeat haemophilia and growth disorders.
Novo Nordisk insulins have been present in India from 1935, marking more than 80 years of uninterrupted supply in the country. The India arm started operations in 1992 with its headquarters in Bengaluru with 26 employees. Since then the company has grown to over 1200 employees, becoming the 5th largest and the fastest growing pharmaceutical MNC in India.
Novo Nordisk India’s portfolio of products addresses diabetes, human growth hormone and haemostasis management.